WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002030966) ALZHEIMER'S DISEASE-ASSOCIATED PROTEINS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/030966    International Application No.:    PCT/US2001/031076
Publication Date: 18.04.2002 International Filing Date: 03.10.2001
Chapter 2 Demand Filed:    26.04.2002    
IPC:
C07K 14/47 (2006.01)
Applicants: INCYTE GENOMICS, INC. [US/US]; 3160 Porter Drive, Palo Alto, CA 94304 (US) (For All Designated States Except US).
XU, Yuming [US/US]; (US) (For US Only).
THANGAVELU, Kavitha [IN/US]; (US) (For US Only).
ELLIOTT, Vicki, S. [US/US]; (US) (For US Only).
TANG, Y., Tom [US/US]; (US) (For US Only).
YUE, Henry [US/US]; (US) (For US Only).
CHAWLA, Narinder, K. [US/US]; (US) (For US Only)
Inventors: XU, Yuming; (US).
THANGAVELU, Kavitha; (US).
ELLIOTT, Vicki, S.; (US).
TANG, Y., Tom; (US).
YUE, Henry; (US).
CHAWLA, Narinder, K.; (US)
Agent: HAMLET-COX, Diana; Incyte Genomics, Inc., 3160 Porter Drive, Palo Alto, CA 94304 (US)
Priority Data:
60/238,391 06.10.2000 US
Title (EN) ALZHEIMER'S DISEASE-ASSOCIATED PROTEINS
(FR) PROTEINES ASSOCIEES A LA MALADIE D'ALZHEIMER
Abstract: front page image
(EN)The invention provides human Alzheimer's disease-associated proteins (ADP) and polynucleotides which identify and encode ADP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of ADP.
(FR)L'invention concerne des protéines associées à la maladie d'Alzheimer et des polynucléotides identifiant et codant lesdites protéines. L'invention concerne également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes, et des antagonistes. L'invention concerne par ailleurs des procédés de diagnostic, de traitement, ou de prévention de troubles associés à l'expression aberrante des protéines associées à la maladie d'Alzheimer.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)